CD47
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2jjs.png|left|200px|thumb|Crystal structure of hCD47 residues 19-136 (mutant) complex with SIRP α [[2jjs]]]] | [[Image:2jjs.png|left|200px|thumb|Crystal structure of hCD47 residues 19-136 (mutant) complex with SIRP α [[2jjs]]]] | ||
| - | {{STRUCTURE_2jjs| PDB=2jjs | SIZE=400| SCENE= |right|CAPTION=hCD47 residues 19-136 (mutant) (pink and yellow) complex with SIRP α (grey and green) | + | {{STRUCTURE_2jjs| PDB=2jjs | SIZE=400| SCENE= |right|CAPTION=hCD47 residues 19-136 (mutant) (pink and yellow) complex with SIRP α (grey and green) and I- ions [[2jjs]] }} |
| Line 22: | Line 22: | ||
| - | '''CD47 (Cluster of Differentiation 47)''' is a protein which is expressed by cancer cells to avoid detection by the immune system. | + | '''CD47 (Cluster of Differentiation 47)''' is a protein which is expressed by cancer cells to avoid detection by the immune system. CD47 consists of an extracellular N-terminal immunoglobulin-like domain, a transmembrane domain and a C-terminal intracellular domain. CD47 is a receptor for thrombospondin-1 and their association influences cell migration and adhesion. CD47 is a receptor for SIRP1 and their association influences inhibition of phagocytosis. CD47 is a receptor for several integrins and their association influences cell migration and adhesion. CD47 leads to cell death via apoptosis. Antibodies against CD47 were found to bring effective cure against cancer in mice in a variety of cancers tested. |
== 3D Structures of CD47 == | == 3D Structures of CD47 == | ||
| Line 28: | Line 28: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | [[2jjs]], [[2jjt]] – hCD47 residues 19-136 (mutant) + SIRP α <br /> | + | [[2jjs]], [[2jjt]], [[4kjy]] – hCD47 residues 19-136 (mutant) + SIRP α <br /> |
[[2vsc]] – hCD47 residues 19-136 (mutant) <br /> | [[2vsc]] – hCD47 residues 19-136 (mutant) <br /> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 06:46, 1 July 2013
CD47 (Cluster of Differentiation 47) is a protein which is expressed by cancer cells to avoid detection by the immune system. CD47 consists of an extracellular N-terminal immunoglobulin-like domain, a transmembrane domain and a C-terminal intracellular domain. CD47 is a receptor for thrombospondin-1 and their association influences cell migration and adhesion. CD47 is a receptor for SIRP1 and their association influences inhibition of phagocytosis. CD47 is a receptor for several integrins and their association influences cell migration and adhesion. CD47 leads to cell death via apoptosis. Antibodies against CD47 were found to bring effective cure against cancer in mice in a variety of cancers tested.
3D Structures of CD47
Updated on 01-July-2013
2jjs, 2jjt, 4kjy – hCD47 residues 19-136 (mutant) + SIRP α
2vsc – hCD47 residues 19-136 (mutant)
